Technology ID
TAB-4642
Candida auris Isolate (B11903) for Diagnostic and Therapeutic Development
E-Numbers
E-078-2017-0
Lead Inventor
Lockhart, Shawn
Lead IC
CDC
ICs
CDC
Applications
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Immunology
Development Stages
Pre-Clinical (in vitro)
Research Products
Plasmids/Vectors
Human Cell Lines
Computational models/software
This technology includes an isolate of the yeast species Candida auris to be used in the development of diagnostic tools or anti-fungal for therapeutic use.
Commercial Applications
Antimicrobial susceptibility testing and microbial identification.
Competitive Advantages
Candida auris is an emerging fungus that presents a serious global health threat.
Licensing Contact: